Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
Georgianos, P. I., Sarafidis P. A., Sinha A. D., & Agarwal, iv R. (2015).  Adverse effects of conventional thrice-weekly hemodialysis: is it time to avoid 3-day interdialytic intervals?. Am J Nephrol. 41(4-5), 400-8.
Georgianos, P. I., Vaios V., Leontaridou E., Karayannopoulou G., Koletsa T., Sioulis A., et al. (2019).  Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab.. Case Rep Nephrol. 2019, 3614980.
Georgianos, P. I., Champidou E., Liakopoulos V., Balaskas E. V., & Zebekakis P. E. (2018).  Home blood pressure-guided antihypertensive therapy in chronic kidney disease: more data are needed.. J Am Soc Hypertens. 12(4), 242-247.
Georgianos, P. I., Vaios V., Eleftheriadis T., Papachristou E., & Liakopoulos V. (2023).  Therapeutic Advances in Diabetic Kidney Disease.. Int J Mol Sci. 24(3), 
Georgianos, P. I., Tziatzios G., Roumeliotis S., Vaios V., Sgouropoulou V., Tsalikakis D. G., et al. (2023).  Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis.. Nephrol Dial Transplant. 38(1), 203-211.
Georgianos, P. I., Pikilidou M. I., Liakopoulos V., Balaskas E. V., & Zebekakis P. E. (2018).  Arterial stiffness in end-stage renal disease-pathogenesis, clinical epidemiology, and therapeutic potentials.. Hypertens Res. 41(5), 309-319.
Georgianos, P. I., & Sarafidis P. A. (2015).  Pro: Should we move to more frequent haemodialysis schedules?. Nephrol Dial Transplant. 30(1), 18-22.
Georgianos, P. I., Sarafidis P. A., Haidich A-B., Karpetas A., Stamatiadis D., Nikolaidis P., et al. (2013).  Diverse effects of interdialytic intervals on central wave augmentation in haemodialysis patients.. Nephrol Dial Transplant. 28(8), 2160-9.
Georgianos, P. I., Mpoutsiouki F., Sabani E., Stamatiadis D. N., Liakopoulos V., Balaskas E. V., et al. (2016).  Hemodialysis patients with intradialytic rise in blood pressure display higher baseline aortic stiffness and negligible drop in augmentation index with dialysis.. Int Urol Nephrol. 48(4), 601-8.
Georgianos, P. I., Vaios V., Eleftheriadis T., Zebekakis P. E., & Liakopoulos V. (2020).  Pulse wave velocity assessment for cardiovascular risk prognostication in ESKD: weighing recent evidence.. Curr Vasc Pharmacol.
Georgianos, P. I., Vaios V., Divani M., & Liakopoulos V. (2023).  Should we discontinue RAS-inhibitor therapy in patients with advanced CKD?. Expert Opin Pharmacother.
Georgianos, P. I., Morfesis P., & Zebekakis P. E. (2017).  Exploring the association of arterial stiffness with estimated glomerular filtration rate: another chicken-egg paradigm?. J Hypertens. 35(3), 650-651.
Georgianos, P. I., Vaios V., Sgouropoulou V., & Liakopoulos V. (2022).  The interaction of estimated glomerular filtration rate with circadian blood pressure variation: do not forget the impact of albuminuria.. J Hypertens. 40(7), 1432-1433.
Georgianos, P. I., Sarafidis P. A., & Lasaridis A. N. (2013).  Arterial Stiffness: a Novel Cardiovascular Risk Factor in Kidney Disease Patients.. Curr Vasc Pharmacol.
Georgianos, P. I., Vaios V., Zebekakis P. E., & Liakopoulos V. (2020).  Blood pressure targets in patients with chronic kidney disease: A critical evaluation of clinical-trial evidence and guideline recommendations.. J Clin Hypertens (Greenwich). 22(5), 924-928.
Georgianos, P. I., Sarafidis P. A., Karpetas A., Kosmidis D., Sioulis A., Liakopoulos V., et al. (2014).  Hemodiafiltration does not have additional benefits over hemodialysis on arterial stiffness, wave reflections and central aortic pressures.. Blood Purif. 37(1), 18-26.
Georgianos, P. I., Sarafidis P. A., Liakopoulos V., Balaskas E. V., & Zebekakis P. E. (2016).  Mineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues.. J Clin Hypertens (Greenwich). 18(3), 197-9.
Georgianos, P. I., Divani M., Eleftheriadis T., Mertens P. R., & Liakopoulos V. (2019).  SGLT-2 inhibitors in Diabetic Kidney Disease: What Lies Behind their Renoprotective Properties?. Curr Med Chem. 26(29), 5564-5578.
Georgianos, P. I., Liampas I., Kyriakou A., Vaios V., Raptis V., Savvidis N., et al. (2017).  Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.. Int Urol Nephrol. 49(12), 2217-2221.
Georgianos, P. I., Dounousi E., & Liakopoulos V. (2023).  Albuminuria and cardiorenal risk.. Curr Opin Cardiol.
Georgianos, P. I., Eleftheriadis T., & Liakopoulos V. (2023).  Combination therapy with an SGLT-2 inhibitor and finerenone in DKD: Are we there yet?. Eur J Clin Invest. 53(2), e13864.
Georgianos, P. I., Sarafidis P. A., & Liakopoulos V. (2015).  Arterial Stiffness: A Novel Risk Factor for Kidney Injury Progression?. Am J Hypertens. 28(8), 958-65.
Georgianos, P. I., Vaios V., Sgouropoulou V., Eleftheriadis T., Tsalikakis D. G., & Liakopoulos V. (2022).  Hypertension in Dialysis Patients: Diagnostic Approaches and Evaluation of Epidemiology.. Diagnostics (Basel). 12(12), 
Georgianos, P. I., Vaios V., Eleftheriadis T., Zebekakis P., & Liakopoulos V. (2017).  Mineralocorticoid Antagonists in ESRD: An Overview of Clinical Trial Evidence.. Curr Vasc Pharmacol. 15(6), 599-606.
Georgianos, P. I., & Sarafidis P. A. (2015).  Opponent's comment.. Nephrol Dial Transplant. 30(1), 27-8.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές